Effect of immunostimulating agents on viral infections.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D006561:Herpes Simplex / Q000628:therapy; D007542:Inosine Pranobex / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008264:Macrophages / Q000276:immunology; D051379:Mice; D009161:Mycobacterium / Q000276:immunology; D009976:Orthomyxoviridae Infections / Q000628:therapy; D010587:Phagocytosis; D011425:Propionibacterium acnes / Q000276:immunology; D014777:Virus Diseases / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D007978:Levamisole; D007542:Inosine Pranobex